"Our gynecologic oncology specialists at Ascension Medical Group - St. Vincent - Women's Gynecologic Cancer Care in Indianapolis, Indiana, deliver cancer care that is right for you. We understand that choosing the right care team is an important decision for you and your family. At Ascension St. Vincent, we deliver compassionate, personalized care for women close to home. We specialize in non-surgical and surgical care for ovarian, uterine, cervical, and other female reproductive cancers. We help you manage menopause symptoms and cancer risk factors and we’ll work together to develop the right treatment plan for you."

During the past decade, St. Vincent Gynecologic Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincent Gynecologic Oncology" #1 sponsor was "Morphotek" with 3 trials, followed by "Telik" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "ImmunoGen, Inc." with 1 trials sponsored and "Onconova Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincent Gynecologic Oncology" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincent Gynecologic Oncology" are "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials), "Ovarian Neoplasms" (2 trials) and "Leiomyosarcoma" (1 trials). Many other conditions were trialed in "St. Vincent Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "St. Vincent Gynecologic Oncology" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Farletuzumab" (2 trials), "0.9% Saline" (1 trials), "Carboplatin" (1 trials), "Chemo Plus Far" (1 trials) and "Farletuzumab-matched placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincent Gynecologic Oncology" are 12 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincent Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in St. Vincent Gynecologic Oncology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincent Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".